Home Ingredients PepForm® Arginine Peptides (L-Arginine — Glanbia Nutritionals)
CardiovascularAthletic PerformanceMen's Health

PepForm® Arginine Peptides (L-Arginine — Glanbia Nutritionals)

Evidence Level
Moderate
2 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

PepForm® Arginine Peptides bind free L-arginine to whey-derived peptides, improving the solubility and palatability of an amino acid that is otherwise bitter. L-arginine is a direct precursor to nitric oxide, the signaling molecule behind blood-vessel dilation, and is studied for circulation, blood pressure, exercise blood flow, and erectile function. Honest framing: arginine's oral bioavailability is limited (citrulline is often more efficient at raising arginine), and PepForm's absorption claims are manufacturer data.

Studied Dose 3–6 g/day, sometimes higher.
Active Compound L-Arginine bound to whey-derived peptides (PepForm® peptide carrier).

Benefits

Nitric oxide and circulation support

Arginine is the substrate the body converts into nitric oxide, which relaxes and widens blood vessels, supporting healthy circulation and blood flow.

Supported by Trial 1, Trial 2

Blood pressure support

Umbrella reviews of meta-analyses report L-arginine can modestly support healthy blood pressure, consistent with its nitric-oxide mechanism.

Supported by Trial 1, Trial 2

Exercise blood flow and men's health

Arginine is used for exercise 'pump' and for erectile and circulatory support, though oral citrulline often raises arginine levels more reliably.

Supported by Trial 1, Trial 2

Erectile function scores, studied in men with mild to moderate ED

A pooled analysis of 10 randomized trials in 540 men with mild to moderate ED found oral L-arginine at 1,500 to 5,000 mg a day improved erectile function, orgasm and satisfaction scores versus placebo or no treatment, but not sexual desire. Some trials paired arginine with other ingredients. A review of 4 trials found PDE5 inhibitor drugs worked better than arginine. Tested as free L-arginine, not PepForm.

Supported by Trial 2, Trial 1

Mechanism of action

1

Nitric oxide synthesis

Arginine is converted by nitric oxide synthase into nitric oxide, a vasodilator that improves endothelial function and blood flow.

2

Peptide-bound delivery

Carrying arginine on whey peptides improves solubility and taste and, per the manufacturer, absorption versus the free amino acid.

Clinical trials

1
L-Arginine Umbrella Review

Umbrella review of meta-analyses (Journal of Chiropractic Medicine, 2016).

Pooled cardiovascular and clinical populations

Across meta-analyses, L-arginine showed benefits for blood pressure and endothelial/circulatory measures, with effect sizes varying by population.

2
L-Arginine/L-Citrulline in Pre-Eclampsia — Meta-Analysis

Systematic review and meta-analysis of L-arginine and L-citrulline for prevention and treatment of pre-eclampsia (pregnancy-related high blood pressure). (Makama et al. 2025, BJOG)

Pregnant women at risk of, or with, pre-eclampsia.

L-arginine and L-citrulline supported blood-pressure outcomes in pre-eclampsia through nitric-oxide signaling. This population is pregnancy-specific and does not directly test the athletic or men’s-health uses.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated; mild gastrointestinal upset is the most common complaint.
Can lower blood pressure, so caution if already on blood-pressure medication.
Contains whey-derived peptides; avoid with milk allergy.
People with herpes (HSV) sometimes find high arginine triggers outbreaks.

Important Drug interactions

Antihypertensives and nitrates: additive blood-pressure lowering — caution.
PDE5 inhibitors (e.g., sildenafil): additive vasodilation; use cautiously.
Anticoagulants: theoretical mild additive effect.
Diabetes medications: monitor, as arginine can affect insulin/glucose.

More Cardiovascular Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids are polyunsaturated fats. EPA and DHA come from fish, krill and algae…
Cardiovascular
CoEnzyme Q10
Coenzyme Q10 (CoQ10) is a fat-soluble compound the body makes for itself. It carries elect…
Cardiovascular
Beetroot
Beetroot is a vegetable rich in dietary nitrate, which the body converts into nitric oxide…
Cardiovascular
Potassium
Potassium is the main mineral inside the body's cells and an essential nutrient for the el…

Explore Other Ingredients

Athletic Performance
L-Citrulline
L-citrulline is an amino acid found in watermelon and sold as plain L-citrulline or as cit…
Cardiovascular
L-Arginine
L-arginine is an amino acid the body uses to make nitric oxide, which relaxes blood vessel…
Athletic Performance
Nitrosigine® (Arginine Silicate)
Nitrosigine® (Nutrition 21) is a patented, inositol-stabilized arginine silicate complex e…

Frequently asked questions about PepForm® Arginine Peptides (L-Arginine — Glanbia Nutritionals)

Is arginine or citrulline better?

Both raise nitric oxide, but oral L-citrulline often increases blood arginine levels more reliably than arginine itself, because arginine is heavily broken down in the gut and liver. PepForm offers both as peptide-bound forms; citrulline is often preferred for the 'pump' effect.

What does PepForm Arginine do?

It supplies L-arginine in a soluble, better-tasting peptide-bound form to support nitric-oxide production, which underlies its use for circulation, blood pressure, exercise blood flow, and erectile support.

What is PepForm Arginine Peptides?

PepForm® Arginine Peptides bind free L-arginine to whey-derived peptides, improving the solubility and palatability of an amino acid that is otherwise bitter. L-arginine is a direct precursor to nitric oxide, the signaling molecule behind blood-vessel dilation, and is studied for circulation, blood pressure, exercise b…

What is PepForm Arginine Peptides used for?

PepForm Arginine Peptides is researched primarily for Cardiovascular, Athletic Performance, and Men's Health. Arginine is the substrate the body converts into nitric oxide, which relaxes and widens blood vessels, supporting healthy circulation and blood flow.

What is the recommended dosage of PepForm Arginine Peptides?

The clinically studied dose is 3–6 g/day, sometimes higher. Always follow the product label and check with a healthcare provider for personal advice.

Is PepForm Arginine Peptides safe, and does it have side effects?

Side effects and cautions reported for PepForm Arginine Peptides include: Generally well tolerated; mild gastrointestinal upset is the most common complaint. Can lower blood pressure, so caution if already on blood-pressure medication. It may also interact with some medications. PepForm Arginine Peptides is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does PepForm Arginine Peptides interact with any medications?

Possible interactions include: Antihypertensives and nitrates: additive blood-pressure lowering — caution. PDE5 inhibitors (e.g., sildenafil): additive vasodilation; use cautiously. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for PepForm Arginine Peptides?

NutraSmarts rates the evidence for PepForm Arginine Peptides as Moderate (3 out of 5). It is backed by 2 study summaries and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. McRae MP Therapeutic Benefits of l-Arginine: An Umbrella Review of Meta-analyses. Journal of Chiropractic Medicine. 2016;15(3):184-9. doi: 10.1016/j.jcm.2016.06.002.PubMedUsed to support: An umbrella review of meta-analyses on L-arginine, covering its nitric-oxide-mediated cardiovascular and circulatory benefits that underpin PepForm Arginine Peptides.
  2. Makama M, McDougall ARA, Cao J, Mills K, Nguyen PY, Hastie R, et al. L-Arginine and L-Citrulline for Prevention and Treatment of Pre-Eclampsia: A Systematic Review and Meta-Analysis. BJOG: An International Journal of Obstetrics and Gynaecology. 2025;132(6):698-708. doi: 10.1111/1471-0528.18070.PubMedUsed to support: A systematic review and meta-analysis of L-arginine and L-citrulline in pre-eclampsia (pregnancy-related hypertension); supports the general nitric-oxide/blood-pressure rationale, though the studied population is pregnancy-specific rather than the product’s athletic or men’s-health target.
  3. Rhim HC, Kim MS, Park YJ, Choi WS, Park HK, Kim HG, Kim A, Paick SH. The Potential Role of Arginine Supplements on Erectile Dysfunction: A Systemic Review and Meta-Analysis. J Sex Med. 2019;16(2):223-234. doi: 10.1016/j.jsxm.2018.12.002.PubMedUsed to support: Systematic review and meta-analysis of 10 RCTs (540 men with mild to moderate erectile dysfunction). Arginine supplements at 1,500 to 5,000 mg improved ED vs placebo or no treatment (OR 3.37, 95% CI 1.29 to 8.77) and improved the IIEF erectile function, orgasmic function and satisfaction subdomains, but not sexual desire. Adverse events were 8.3% vs 2.3%, none severe. The pool includes arginine combined with other substances, and the free amino acid was studied, not a peptide-bound form. Backs the Men's Health erectile-function benefit.
  4. Xu Z, Liu C, Liu S, Zhou Z. Comparison of efficacy and safety of daily oral L-arginine and PDE5Is alone or combination in treating erectile dysfunction: A systematic review and meta-analysis of randomised controlled trials. Andrologia. 2021;53(4):e14007. doi: 10.1111/and.14007.PubMedUsed to support: Meta-analysis of 4 RCTs (373 patients) comparing oral L-arginine, PDE5 inhibitors and their combination for erectile dysfunction. PDE5 inhibitors alone beat L-arginine alone on sexual function index, and the combination beat either alone, with no significant increase in adverse events. Backs the statement that arginine is weaker than first-line drugs.